Vimentin as a multifaceted player and potential therapeutic target in viral infections
Vimentin is an intermediate filament protein that plays key roles in integration of cytoskeletal
functions, and therefore in basic cellular processes such as cell division and migration …
functions, and therefore in basic cellular processes such as cell division and migration …
Negri bodies and other virus membrane-less replication compartments
Q Nevers, AA Albertini, C Lagaudrière-Gesbert… - … et Biophysica Acta (BBA …, 2020 - Elsevier
Viruses reshape the organization of the cell interior to achieve different steps of their cellular
cycle. Particularly, viral replication and assembly often take place in viral factories where …
cycle. Particularly, viral replication and assembly often take place in viral factories where …
COVID-19 in children: initial characterization of the pediatric disease
AT Cruz, SL Zeichner - Pediatrics, 2020 - publications.aap.org
POTENTIAL CONFLICT OF INTEREST: The University of Virginia has filed patent
applications related to new technologies for the rapid production of vaccines, and Dr …
applications related to new technologies for the rapid production of vaccines, and Dr …
The large action of chlorpromazine: translational and transdisciplinary considerations in the face of COVID-19
Coronavirus disease 2019 (COVID-19) is a severe acute respiratory syndrome (SARS) in
humans that is caused by SARS-associated coronavirus type 2 (SARS-CoV-2). In the …
humans that is caused by SARS-associated coronavirus type 2 (SARS-CoV-2). In the …
Vimentin as a target for the treatment of COVID-19
Z Li, D Paulin, P Lacolley… - BMJ open …, 2020 - bmjopenrespres.bmj.com
We and others propose vimentin as a possible cellular target for the treatment of COVID-19.
This innovative idea is so recent that it requires further attention and debate. The significant …
This innovative idea is so recent that it requires further attention and debate. The significant …
Human enterovirus group B viruses rely on vimentin dynamics for efficient processing of viral nonstructural proteins
P Turkki, M Laajala, M Flodström-Tullberg… - Journal of …, 2020 - Am Soc Microbiol
We report that several viruses from the human enterovirus group B cause massive vimentin
rearrangements during lytic infection. Comprehensive studies suggested that viral protein …
rearrangements during lytic infection. Comprehensive studies suggested that viral protein …
Systems biology approaches for therapeutics development against COVID-19
Understanding the systems biology approaches for promoting the development of new
therapeutic drugs is attaining importance nowadays. The threat of COVID-19 outbreak …
therapeutic drugs is attaining importance nowadays. The threat of COVID-19 outbreak …
Arginine‐enveloped virus inactivation and potential mechanisms
C Meingast, CL Heldt - Biotechnology Progress, 2020 - Wiley Online Library
Arginine synergistically inactivates enveloped viruses at a pH or temperature that does little
harm to proteins, making it a desired process for therapeutic protein manufacturing …
harm to proteins, making it a desired process for therapeutic protein manufacturing …
Cellular vimentin interacts with foot-and-mouth disease virus nonstructural protein 3A and negatively modulates viral replication
X Ma, Y Ling, P Li, P Sun, Y Cao, X Bai, K Li… - Journal of …, 2020 - Am Soc Microbiol
Nonstructural protein 3A of foot-and-mouth disease virus (FMDV) is a partially conserved
protein of 153 amino acids that is in most FMDVs examined to date, and it plays important …
protein of 153 amino acids that is in most FMDVs examined to date, and it plays important …
Fluorescent tagged vaccinia virus genome allows rapid and efficient measurement of oncolytic potential and discovery of oncolytic modulators
F Gallardo, D Schmitt, R Brandely, C Brua, N Silvestre… - Biomedicines, 2020 - mdpi.com
As a live biologic agent, oncolytic vaccinia virus has the ability to target and selectively
amplify at tumor sites. We have previously reported that deletion of thymidine kinase and …
amplify at tumor sites. We have previously reported that deletion of thymidine kinase and …